The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies
Abstract
Mitochondrial function is vital for normal cellular processes. Mitochondrial damage and oxidative stress have been greatly implicated in the progression of aging, along with the pathogenesis of age‐related neurodegenerative diseases (NDs), such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Although antioxidant therapy has been proposed for the prevention and treatment of age‐related NDs, unraveling the molecular mechanisms of mitochondrial dysfunction can lead to significant progress in the development of effective treatments against such diseases. Aging is associated with the generation and accumulation of reactive oxygen species (ROS) that are the major contributors to oxidative stress. Oxidative stress is caused because of the imbalance between the production of ROS and their oxidation, which can affect the mitochondrial respiratory chain function, thereby altering the membrane permeability and calcium homeostasis, along with increasing the heteroplasmic mtDNA and weakening the mitochondrial defense systems. Mitochondrial dysfunction mainly affects mitochondrial biogenesis and dynamics that are prominent in several age‐related NDs. Mitochondrial dysfunction has a crucial role in the pathophysiology of age‐related NDs. Several mitochondria targeted strategies, such as enhancing the antioxidant bioavailability via novel delivery systems, identifying unique mitochondrial proteins as specific drug targets, investigating the signaling pathways of mitochondrial biogenesis and dynamics, and identifying effective natural products are potentially effective to counteract mitochondrial dysfunction‐related NDs. Graphical abstract Figure. No Caption available. HighlightsMitochondrial damage is associated with aging phenomena.Mitochondrial dysfunction leads to the development of several age‐related neurodegenerative disorders.Oxidative stress and mutations are the key contributors to mitochondrial damage.Lifestyle habits and specific pharmacological interventions can ameliorate the consequences of mitochondrial dysfunction associated with aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–206 of 206
Bcl-2 family and the central nervous system: from rheostat to real complex
Shacka, J. J., & Roth, K. A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401974 · Cited by 26
Revisiting trends on mitochondrial mega-channels for the import of proteins and nucleic acids
Campo, M. L., Peixoto, P. M. V., & Martinez‐Caballero, S. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9662-z · Cited by 22
Suzuki, Y. (2012) · Sensors · doi:10.3390/s120100549 · Cited by 20
Harnessing the Stem Cell Potential: The path to prevent mitochondrial disease
Tanaka, A., Sauer, M. V., Egli, D. M., & Kort, D. H. (2013) · Nature Medicine · doi:10.1038/nm.3422 · Cited by 20
Salvaging hope: Is increasing NAD+ a key to treating mitochondrial myopathy?
Lightowlers, R. N., & Chrzanowska‐Lightowlers, Z. M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404179 · Cited by 17
Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease
Brazier, M. W., Wedd, A. G., & Collins, S. J. (2014) · Antioxidants · doi:10.3390/antiox3020288 · Cited by 14
Cited by
Mitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 602
Monzio Compagnoni, G., Di Fonzo, A., Corti, S., Comi, G. P., Bresolin, N., & Masliah, E. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01926-1 · Cited by 378
Mitochondrial dysfunction in aging
Guo, Y., Guan, T., Shafiq, K., Yu, Q., Jiao, X., Na, D., Li, M., Zhang, G., & Kong, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101955 · Cited by 339
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
Avallone, R., Vitale, G., & Bertolotti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174256 · Cited by 218
Li, Y., Peng, Y., Shen, Y., Zhang, Y., Liu, L., & Yang, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2076064 · Cited by 156
Metadata
- Authors
- Elfawy, H. A., & Das, B.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 218
- Pages
- 165-184
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2906548750
- Cited by
- 343
- References
- 206
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.